Renaissance Technologies
CTOR

Renaissance Technologies’s Citius Oncology, Inc. Common Stock CTOR Stock Holding History

Renaissance Technologies’s Portfolio CTOR Stock Details CTOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,196
Closed -$12.9K – 3927
2024
Q4 		$12.9K Buy
+11,196
New +$12.9K ﹤0.01% 3507